Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-06-21 09:03 Tx date 2024-06-17 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,360
+27,200 vol $3.80 each |
163,307 | |
Filed 2023-06-12 09:40 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
136,107 | |
Filed 2023-06-09 15:58 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
Filed 2023-06-09 15:58 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
136,107 | |
Filed 2022-05-16 15:04 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
108,907 | |
Filed 2021-05-17 15:44 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
59,907 | |
Filed 2021-05-14 12:46 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
Filed 2021-05-14 12:46 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
59,907 | |
Filed 2020-07-02 20:05 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$80,000
+4,000 vol $20.00 each |
4,000 | |
Filed 2020-07-02 20:03 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-02 20:02 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
38,907 |